Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

ImmunityBio Aktie: Neue Studie


ImmunityBio schiebt seine Krebs-Pipeline weiter an – und setzt dabei auf einen Ansatz, der…

Der Beitrag ImmunityBio Aktie: Neue Studie erschien zuerst auf kapitalmarktexperten.de.


Quelle kapitalmarktexperten.de

ImmunityBio Inc. Stock

€6.58
2.080%
There is an upward development for ImmunityBio Inc. compared to yesterday, with an increase of €0.13 (2.080%).


Comments